EP Biocomposites Limited (BOM:543595)

EP Biocomposites Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	120.06	114.39	71.31	80.6	29.48
Revenue	120.06	114.39	71.31	80.6	29.48
Revenue Growth (YoY)	4.96%	60.42%	-11.52%	173.39%	-13.54%
Cost of Revenue	77.19	70.09	41.22	49.76	18.18
Gross Profit	42.87	44.31	30.09	30.84	11.3
Selling, General & Admin	15.7	24.26	15.95	12.96	4.72
Other Operating Expenses	8.33	3.72	3.42	4.05	1.98
Operating Expenses	25.16	28.98	20.36	17.67	6.71
Operating Income	17.72	15.33	9.72	13.17	4.6
Interest Expense	-3.55	-0.35	-2.03	-1.56	-
Interest & Investment Income	-	0.73	0.45	0.06	0.03
Other Non Operating Income (Expenses)	-	-0	-0	-	0.02
Pretax Income	14.17	15.7	8.14	11.66	4.64
Income Tax Expense	3.86	4.21	2.38	3.57	1.06
Net Income	10.31	11.5	5.76	8.09	3.58
Net Income to Common	10.31	11.5	5.76	8.09	3.58
Net Income Growth	-10.33%	99.55%	-28.82%	126.09%	88.82%
Shares Outstanding (Basic)	2	2	1	1	0
Shares Outstanding (Diluted)	2	2	1	1	0
Shares Change (YoY)	0.00%	15.13%	71.17%	127.55%	-
EPS (Basic)	6.13	6.84	3.94	9.49	9.55
EPS (Diluted)	6.13	6.84	3.94	9.48	9.55
EPS Growth	-10.34%	73.52%	-58.44%	-0.70%	-
Free Cash Flow	-5.02	-14.8	-8.17	-47.55	0.32
Free Cash Flow Per Share	-2.98	-8.80	-5.59	-55.72	0.85
Gross Margin	35.71%	38.73%	42.19%	38.26%	38.34%
Operating Margin	14.76%	13.40%	13.63%	16.34%	15.60%
Profit Margin	8.59%	10.05%	8.08%	10.04%	12.14%
Free Cash Flow Margin	-4.18%	-12.94%	-11.45%	-58.99%	1.08%
EBITDA	18.84	16.33	10.72	13.83	4.6
EBITDA Margin	15.69%	14.28%	15.03%	17.16%	15.61%
D&A For EBITDA	1.13	1.01	1	0.66	0
EBIT	17.72	15.33	9.72	13.17	4.6
EBIT Margin	14.76%	13.40%	13.63%	16.34%	15.60%
Effective Tax Rate	27.26%	26.79%	29.22%	30.58%	22.88%
Revenue as Reported	121.15	117.38	72.97	80.76	29.52
Advertising Expenses	-	0.29	0.19	0.11	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.